As we close the third quarter of 2026, NutriSelect.ai has entered an important new stage in its evolution.
During Q2, much of our work centered on defining and advancing the architecture behind the Precision Supplement Intelligence™ Platform—establishing the scientific, technical, and strategic foundation required to build something far more ambitious than another supplement recommendation application.
Q3 has been about turning that architecture into execution.
We have continued translating our scientific methodologies into operational systems, advancing the NScore™ Engine and platform infrastructure, preparing for validation, expanding the scientific ecosystem around NutriSelect, and beginning the transition from platform development toward market activation.
At the same time, we have been building the community that will help shape the next phase of NutriSelect through the Founding 1,000.
The vision remains unchanged: to become the global intelligence standard for evidence-based supplementation.
Quarter by quarter, that vision is becoming increasingly tangible.
— Dr. Bill Clark, PhD
Founder & CEO, NutriSelect.ai
Platform & Intelligence Infrastructure
Market Activation
Science & Ecosystem
Intelligence & Thought Leadership
Strategic Growth
One of the most important developments during Q3 has taken place largely behind the scenes. The scientific methodologies and product vision underpinning NutriSelect are increasingly being translated into operational architecture.
At the center of that work is the Precision Supplement Intelligence™ Platform—a continuously learning intelligence infrastructure designed to transform scientific research, ingredient intelligence, product intelligence, regulatory information, and ultimately Real-World Evidence into structured, decision-grade intelligence.
Development during the quarter continued across the NScore™ Engine and the Ingredient Studio™ and Product Studio™ environments that will operationalize scientific assessments.
Just as importantly, we have continued developing the architecture surrounding those systems—including validation and quality assurance, security, auditability, and the controls required to ensure that scientific intelligence remains traceable, consistent, and trustworthy as the platform scales.
This work is foundational.
NutriSelect is not simply digitizing a scoring methodology. We are building the infrastructure through which scientific evidence can be evaluated, transformed into intelligence, measured through NScore™, and ultimately delivered across consumer, practitioner, industry, and enterprise applications.
The objective is not more information. The objective is better intelligence.
Technology alone does not create transformation. People do.
During Q3, we began preparing one of our most important market activation initiatives: The Founding 1,000.
The Founding 1,000 is designed to bring together the first community of consumers and advocates who believe supplement decisions should be driven by evidence, transparency, and intelligence rather than marketing noise. These early participants represent more than an initial user base. They will help us learn. Their experiences, questions, expectations, and ultimately their interactions with the platform will help inform how NutriSelect evolves as we move toward broader adoption.
That makes the Founding 1,000 an important extension of our broader philosophy: build carefully, listen continuously, learn from real-world interaction, and improve. The transition from development to market begins with a community willing to help shape what comes next.
The value of the Precision Supplement Intelligence™ Platform will ultimately depend not only on technology, but on the quality and breadth of the intelligence flowing through it. That is why ecosystem development remains a strategic priority.
Throughout Q3, we continued strengthening relationships across the supplement value chain—including ingredient suppliers, product brands, clinical research organizations, laboratories, scientific advisors, technology partners, and other organizations committed to evidence-based innovation.
Each participant contributes something different:
Together, these relationships contribute to an expanding intelligence network in which every high-quality dataset has the potential to strengthen future assessments. This is the foundation of the NutriSelect Data Flywheel™:
More trusted data → stronger intelligence → better assessments → greater platform value → more participation → more trusted data.
The ecosystem and the platform grow stronger together.
The Science Accelerator™ continues to play an important role in connecting industry participation with the Precision Supplement Intelligence™ Platform. Designed for ingredient suppliers and product brands, the Accelerator provides a structured pathway for organizations to evaluate scientific credibility, identify evidence gaps, and develop strategies for scientific advancement.
During Q3, work continued on the assessment workflows and intelligence infrastructure required to support ingredient and product evaluations. The Accelerator is intentionally designed to do more than produce an NScore™.
Its purpose is to help answer a more valuable question:
What can an organization do next to strengthen its scientific position?
Through assessments, gap analyses, research roadmaps, scientific benchmarking, and access to aligned research and laboratory resources, the Science Accelerator™ transforms evaluation into advancement.
At the same time, participating organizations contribute high-quality scientific datasets that strengthen the broader NutriSelect intelligence ecosystem. Scientific advancement and platform advancement become mutually reinforcing.
Earlier this year, our Supplement Use & Perception Study provided important insights into how consumers think about supplementation, scientific credibility, artificial intelligence, personalization, privacy, and trust.
During Q3, those findings continued informing our thinking about the NutriSelect experience.
One lesson has been particularly important:
Consumers don’t simply need more health information. They need to understand why they should trust the intelligence being presented to them.
That means transparency and explainability cannot be features added later. They must be embedded into the platform from the beginning.
It also reinforces why NutriSelect’s independence matters.
Scientific credibility cannot depend on who manufactures a product, who markets it, or who pays for an assessment. Consistent scientific standards must apply regardless of commercial relationships.
Trust must be designed into the system.
Building a new platform also requires building understanding around the problem it exists to solve. Throughout Q3, NutriSelect continued expanding its thought leadership at the intersection of artificial intelligence, nutrition, supplement science, and scientific credibility.
Through the AI Health Intelligence Brief, industry publications, podcast conversations, interviews, presentations, and ongoing commentary, we have been exploring questions that extend well beyond NutriSelect itself:
These conversations matter because Precision Supplement Intelligence™ represents more than a product category. It represents a different way of thinking about the relationship between science and decision-making.
Our role is not simply to participate in that conversation.
We intend to help define it.
Interest in NutriSelect continues to extend beyond the supplement industry itself.
Throughout Q3, we continued conversations with prospective investors and strategic partners across multiple international markets who recognize the opportunity created by the convergence of artificial intelligence, evidence-based nutrition, scientific data, and consumer demand for greater transparency.
Our approach to capital remains deliberate. We are not simply looking for investment. We are looking for investors who understand what we are building, respect the importance of scientific independence, recognize the long-term value of proprietary intelligence infrastructure, and can contribute strategically to the company’s next stage of growth.
Our Investor Protocols continue to guide those conversations.
The opportunity remains open for the right strategic investors who share our long-term vision.
As we enter the final quarter of the year, our priorities increasingly center on moving intelligence from architecture toward application.
Key priorities include:
The work ahead remains substantial. But the direction is increasingly clear.
NutriSelect began with a question about how consumers could make better supplement decisions.
That question led us to a much larger opportunity: creating the intelligence infrastructure through which scientific credibility itself can become measurable, understandable, actionable, and continuously improvable.
That is the future we are building.
Every dataset strengthens the platform.
Every assessment improves future intelligence.
Every partnership expands the ecosystem.
And every step brings us closer to making scientific credibility measurable, actionable, and accessible across the supplement ecosystem.
